跳至主要内容
临床试验/NCT05730985
NCT05730985Unknown不适用

Effectiveness of the Intake of a Food Supplement Based on Hydroxymethylbutyrate, Carnosine, Lactoferrin and Magnesium on Reduction of Inflammation and on the Improvement of the Health of the Muscle

Azienda di Servizi alla Persona di Pavia2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年10月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
2
主要终点
Muscle strength evaluation

研究概览

简要总结

This research aims to evaluate the effectiveness of a dietary supplement on reducing inflammation and improving muscle health. The product is a food supplement notified to the Ministry of Health consisting of: hydroxymethylbutyrate, carnosine, lactoferrin and magnesium, which help reduce inflammation and intestinal permeability and to improve muscle health.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
55 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • sarcopenic patients aged 55-
  • Sarcopenia will be diagnosed according to the European Working Group on Sarcopenia in Older People (EWSGOP-2) criteria by muscle strength or chair stand test.

排除标准

  • severe kidney disease (glomerular filtration rate <30 mL/min),
  • moderate-to-severe hepatic failure (Child-Pugh Class of B or C),
  • endocrine diseases associated with disorders of calcium metabolism (with the exception of osteoporosis),
  • psychiatric disorders,
  • cancer (in the previous 5 years),
  • hypersensitivity to any investigational food component
  • subjects taking protein/amino acid supplements (up to 3 months prior to the study).
  • patients not capable of taking oral therapy and those receiving or having indication for artificial nutrition or included in another clinical nutrition trial

结局指标

主要结局

Muscle strength evaluation

时间窗: After 4 months of treatment

Muscle strength was measured by handgrip strength according to standard procedures by a hydraulic hand dynamometer (Jamar 5030 J1, Sammons Preston Rolyan, Bolingbrook, Canada with an accuracy of 0.6 N). The subject holds the dy-namometer in the hand to be tested, with the arm at right angles and the elbow by the side of the body, applying an isometric contraction

Inflammation status

时间窗: After 4 months of treatment

A blood sample will be collected and analised for C-reactive protein and tumor necrosis factor alfa (TNF alfa)

body composition assessment

时间窗: After 4 months of treatment

Body composition represented by fat free mass and fat mass were measured using a Lunar Prodigy DXA (GE Medical Systems, WI, USA).

Gut permeability.

时间窗: After 4 months of treatment

A blood sample will be collected and analised for indican

Physical performance assessment

时间窗: After 4 months of treatment

Physical performance was assessed using the Short Physical Performance battery test (SPPB) which comprised of gait speed, chair-stand test, and balance (three different tests that assess the ability to stand with the feet together in the side-by-side, semi-tandem, and tandem positions); each component was scored from 0 (not possible) to 4 (best performance) and the scores were added up to a total score ranging from 0 to 12.

次要结局

未报告次要终点

研究者

发起方
Azienda di Servizi alla Persona di Pavia
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验